Overview

Click here to take the Costs of Attrition Survey

Focusing on Two Interrelated Topics:
• De-Risking Drug Development Decision Making
• Novel Paradigms that Can Positively Impact Drug Development

Program Features:
• Will Systems Biology Improve Decision Making?
• How Can Changes in the R&D Business Model Enable Better Risk Management?
• The Use of Portfolio Management, Therapeutic Area Strategy and Biomarkers to Reduce
   Attrition in Drug Development
• Future Strategic Models of Portfolio Management
• Tangibly Impacting the Predictability of Preclinical and Clinical Testing
• Addressing Bottlenecks within the NCE and NBE Discovery Process
• Making Better Decisions with Imperfect Data
• Novel Approaches to Reducing the Costs of Attrition

Participants:
• Richard M. Bayney, Ph.D., MBA Vice President, Decision Analysis and Portfolio Management, PRD,
   Johnson & Johnson
• Joseph Bolen, Ph.D., Senior Vice President, Research & Drug Discovery, Millennium
   Pharmaceuticals 
• Thomas F. Bumol Ph.D., Vice President, Biotechnology Discovery Research & Applied Molecular Evolution, Lilly Research Laboratories
• Christine Cioffe, Ph.D., Vice President, R&D Portfolio Management, Merck & Co.
• Mikael Dolsten, M.D., Ph.D., Global Head, Pharma Research, Boehringer Ingelheim
   Pharmaceuticals, Inc.
• Richard Heaslip, Ph.D., Vice President, Project & Portfolio Management, Wyeth Research 
• Shama Kajiji, Ph.D., Worldwide Head, Attrition Analysis Office, PGRD, Pfizer Inc. 
• Ismail Kola, Ph.D., Senior Vice President, Site Head for Basic Research, Rahway, Merck
   Research Laboratories 
• Catherine Strader, Ph.D., Executive Vice President, Discovery Research, Schering Plough Research Institute
• James B. Summers, Ph.D., Divisional Vice President, Advanced Technology, Abbott Laboratories

Networking Features Include:
• Executive Roundtable Discussions 
• Four Concurrent, Interactive Breakout Sessions

Call for Sponsors: Showcase your company’s expertise, brand your solutions and develop revenue opportunities with qualified decision-makers by becoming a Sponsor! If you want to discuss sponsoring at this conference, please contact John Yurewicz, Jr. at 781-972-5483, jyurewicz@healthtech.com.